Papapetropoulos Spyros [Rocket]

Date	Name	Symbol	Type	Security	Shares	Price	Value	Reported
05/10/2023	Lipocine Inc.	LPCN	Grant	Stock Option (Right to Buy)	30k	$0.27	$8k	05/10/2023
11/22/2022	Lipocine Inc.	LPCN	Purchase	Common stock	21.7k	$0.47	$10.2k	11/22/2022
11/18/2022	Vigil Neuroscience, Inc.		Sale	Common Stock	300	$14.00	$4.2k	11/18/2022
11/18/2022	Vigil Neuroscience, Inc.		Exercise	Stock Option Grant (Right to Buy)	300	$1.89	$567	11/18/2022
06/08/2022	Lipocine Inc.	LPCN	Grant	Stock Option (Right to Buy)	22k	$0.92	$20.2k	06/08/2022
05/03/2022	Vigil Neuroscience, Inc.		Purchase	Common Stock	4k	$3.40	$13.6k	05/03/2022
04/11/2022	Lipocine Inc.	LPCN	Grant	Stock Option (Right to Buy)	10k	$1.16	$11.6k	04/11/2022
03/01/2022	Vigil Neuroscience, Inc.		Grant	Stock Option Grant (Right to Buy)	75.5k	$16.13	$1.2M	03/01/2022
11/24/2021	Adamas Pharmaceuticals Inc	ADMS	Other	Common Stock	21k	$0.00	$0	11/24/2021
11/24/2021	Adamas Pharmaceuticals Inc	ADMS	Disposition	Stock Option (Right to Buy)	20k	$4.35	$87k	11/24/2021
11/24/2021	Adamas Pharmaceuticals Inc	ADMS	Disposition	Stock Option (Right to Buy)	10k	$5.21	$52.1k	11/24/2021
06/02/2021	Adamas Pharmaceuticals Inc	ADMS	Grant	Common Stock	5k	$0.00	$0	06/02/2021
06/02/2021	Adamas Pharmaceuticals Inc	ADMS	Grant	Stock Option (Right to Buy)	10k	$5.21	$52.1k	06/02/2021
03/11/2021	Adamas Pharmaceuticals Inc	ADMS	Purchase	Common Stock	6k	$5.06	$30.2k	03/11/2021
11/22/2020	Adamas Pharmaceuticals Inc	ADMS	Grant	Common Stock	10k	$0.00	$0	11/22/2020
11/22/2020	Adamas Pharmaceuticals Inc	ADMS	Grant	Stock Option (Rightto Buy)	20k	$4.35	$87k	11/22/2020